The inaugural meeting of the Queensland Molecular Tumour Board (QMTB) was held on the morning of Wednesday, 10th October 2018 at Translational Research Institute, on the grounds of Princess Alexandra Hospital, Brisbane.
The QMTB is an initiative of the Australian Translational Genomics Centre (ATGC), and includes physicians, oncologists,…

This article was produced by QUT Media and published on the QUT News website on 27th August 2018
Cutting-edge DNA sequencing technology has been used by QUT researchers at the new Australian Translational Genomics Centre (ATGC) to identify genetic mutations in 100 patients with blood cancers, with this testing providing clinically…

Monday 22nd January, 2018, Brisbane, Australia.
The ATGC has received NATA approval to use formalin-fixed paraffin-embedded (FFPE) tissue samples for whole-exome sequencing (WES). This involved successful completion of the validation study, and NATA approval that was accepted on 9th January 2018.
For cases where insufficient fresh tumour…

Brisbane, Australia. The TRI Auditorium, Woolloongabba, will be the venue for a Genomic Technologies Fair on Tuesday 7 November, 2017.
TRI will host representative guest speakers from a number of genomics industry leaders. For more information on the program, and to RSVP for catering purposes, please see here.

Wednesday 4th October 2017, Brisbane, Australia. The Australian Translational Genomics Centre (ATGC), based at Queensland University of Technology at Translational Research Institute, and Princess Alexandra Hospital, Woolloongabba, has received accreditation to provide genomic testing of patient samples for clinical reports.
This will…

30th November, 2016, WENZHOU, CHINA: A new Centre for Personalised Medicine opens today at Wenzhou Medical University’s First Affiliated Hospital. It will provide a new world-leading service in personalised medicine genomics for cancer and other patients attending the hospital, and perform cancer research.
Advances in genome sequencing…